File Download

There are no files associated with this item.

Supplementary

Conference Paper: Bioavailability of arsenic trioxide solubalised for oral administration to patients with haemic malignancies (P-11)

TitleBioavailability of arsenic trioxide solubalised for oral administration to patients with haemic malignancies (P-11)
Authors
Issue Date2003
Citation
Sixth Congress of European Association of Clinical Pharmacology adn Therapeutics - European Collaboration: Towards Drug Development and Rational Drug Therapy, p. 73 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/102324

 

DC FieldValueLanguage
dc.contributor.authorKumana, CRen_HK
dc.contributor.authorAu, WYen_HK
dc.contributor.authorLee, NSen_HK
dc.contributor.authorKou, Men_HK
dc.contributor.authorMak, RWMen_HK
dc.contributor.authorLam, CWen_HK
dc.contributor.authorKwong, YLen_HK
dc.date.accessioned2010-09-25T20:26:02Z-
dc.date.available2010-09-25T20:26:02Z-
dc.date.issued2003en_HK
dc.identifier.citationSixth Congress of European Association of Clinical Pharmacology adn Therapeutics - European Collaboration: Towards Drug Development and Rational Drug Therapy, p. 73en_HK
dc.identifier.urihttp://hdl.handle.net/10722/102324-
dc.languageengen_HK
dc.relation.ispartofSixth Congress of European Association of Clinical Pharmacology adn Therapeutics - European Collaboration: Towards Drug Development and Rational Drug Therapyen_HK
dc.titleBioavailability of arsenic trioxide solubalised for oral administration to patients with haemic malignancies (P-11)en_HK
dc.typeConference_Paperen_HK
dc.identifier.emailKumana, CR: hrmekcr@hku.hken_HK
dc.identifier.emailAu, WY: auwing@HKUCC.hku.hken_HK
dc.identifier.emailKwong, YL: ylkwong@hku.hken_HK
dc.identifier.authorityKwong, YL=rp00358en_HK
dc.identifier.hkuros82857en_HK
dc.identifier.spage73en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats